Invention Grant
- Patent Title: C-terminal amidation of polypeptides
- Patent Title (中): 多肽的C-末端酰胺化
-
Application No.: US13822821Application Date: 2011-09-08
-
Publication No.: US09249181B2Publication Date: 2016-02-02
- Inventor: Chengzao Sun , Behrouz Bruce Forood , Gary Luo , Soumitra S. Ghosh
- Applicant: Chengzao Sun , Behrouz Bruce Forood , Gary Luo , Soumitra S. Ghosh
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Mintz, Levin, Cohn, Ferris Glovsky and Popeo, P.C.
- International Application: PCT/US2011/050754 WO 20110908
- International Announcement: WO2012/036962 WO 20120322
- Main IPC: C07K1/00
- IPC: C07K1/00 ; C07K1/107 ; C07D311/88 ; C07C211/27

Abstract:
There are provided compounds and methods for amidating the C-terminus of a polypeptide. The methods include reacting a polypeptide which includes a C-terminal thioester or C-terminal selenoester with any one of a defined set of auxiliary molecules under conditions suitable to produce a polypeptide adduct which includes the auxiliary molecule chemically bound at the C-terminal of the polypeptide. The auxiliary molecule can be a substituted or unsubstituted 2-phenyl-2-amino ethanethiol, a substituted or unsubstituted 2-phenyl-2-amino ethaneselenol, or a substituted xanthene. In the subsequent step, a portion of the auxiliary molecule is removed from the C-terminal of the polypeptide adduct and leaving the amide nitrogen under conditions suitable to form a C-terminal free amide polypeptide.
Public/Granted literature
- US20140058070A1 C-TERMINAL AMIDATION OF POLYPEPTIDES Public/Granted day:2014-02-27
Information query